The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ISHARES CORE SP 500 ETF | ETF | 464287200 | 201,928 | 468,707 | SH | SOLE | 0 | 0 | 0 | 0 | |
| ISHARES CORE U.S. AGGREGATE ETF | ETF | 464287226 | 133,063 | 1,158,777 | SH | SOLE | 0 | 0 | 0 | 0 | |
| COINBASE GLOBAL INC CLASS A | CL A | 19260Q107 | 29,333 | 128,947 | SH | SOLE | 0 | 0 | 0 | 0 | |
| PINDUODUO INC ADR | ADR | 722304102 | 4,006 | 44,184 | SH | SOLE | 0 | 0 | 0 | 0 | |
| XPENG INC | ADS | 98422D105 | 1,364 | 38,370 | SH | SOLE | 0 | 0 | 0 | 0 | |
| FULCRUM THERAPEUTICS INC | COM | 359616109 | 447 | 15,860 | SH | SOLE | 0 | 0 | 0 | 0 | |
| NURIX THERAPEUTICS INC | COM | 67080M103 | 476 | 15,904 | SH | SOLE | 0 | 0 | 0 | 0 | |